{
    "paper_id": "1524db4629abd637fcddf57ed8f1f741bb9e4f50",
    "metadata": {
        "title": "Methylene blue, Mycophenolic acid, Posaconazole, and Niclosamide inhibit SARS-CoV-2Omicron variant BA.1 infection of human airway epithelial explant cultures",
        "authors": [
            {
                "first": "Romain",
                "middle": [],
                "last": "Volle",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Luca",
                "middle": [],
                "last": "Murer",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Anthony",
                "middle": [],
                "last": "Petkidis",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Vardan",
                "middle": [],
                "last": "Andriasyan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Alessandro",
                "middle": [],
                "last": "Savi",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Cornelia",
                "middle": [],
                "last": "Bircher",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Nicole",
                "middle": [],
                "last": "Meili",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Lucy",
                "middle": [],
                "last": "Fischer",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Daniela",
                "middle": [
                    "Policarpo"
                ],
                "last": "Sequeira",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Daniela",
                "middle": [
                    "Katharina"
                ],
                "last": "Mark",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Alfonso",
                "middle": [],
                "last": "Gomez-Gonzalez",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            },
            {
                "first": "Urs",
                "middle": [
                    "F"
                ],
                "last": "Greber",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Z\u00fcrich",
                    "location": {
                        "addrLine": "Winterthurerstrasse 190",
                        "postCode": "8057",
                        "settlement": "Zurich",
                        "country": "Switzerland"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "The causative agent of COVID-19, SARS-CoV-2 rapidly evolves in the human population at high circulation frequency despite increasing natural and vaccine-induced immunity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Variants of concern (VoC) emerge and continue to turn over. For example, the Alpha and Beta VoC were first reported in the UK and South Africa in Summer 2020, and were replaced by the Delta VoC, first reported in India October 2020. Delta soon became the dominant VoC by mid 2021 (3) (4) (5) . Lately, the Omicron variant emerged, as first reported in South Africa in November 2021, and became abundant worldwide from December 2021 onward, replacing Delta by the beginning of 2022 (6) . Omicron variants feature up to at least 30 amino acid substitutions, several deletions and also insertions in the spike protein (S) open reading frame (ORF). Remarkably, many of the substitutions are directly localized within the receptor-binding domain (RBD) (7) , possibly the result of immune pressure upon infection and vaccination (8) (9) (10) (11) . Accordingly, neutralizing antibody titers against Omicron are found to be lower than against earlier VoC, as suggested in a preprint study from 23 laboratories (12) . Nonetheless, Omicron appears to cause less severe disease than Delta, possibly because the immune status of many people still partially protects against Omicron and its VoC. However, Omicron continues to cause death notably affecting also non-vaccinated or incompletely vaccinated individuals (11, 13) .",
            "cite_spans": [
                {
                    "start": 280,
                    "end": 283,
                    "text": "(3)",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 284,
                    "end": 287,
                    "text": "(4)",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 288,
                    "end": 291,
                    "text": "(5)",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 481,
                    "end": 484,
                    "text": "(6)",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 747,
                    "end": 750,
                    "text": "(7)",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 823,
                    "end": 826,
                    "text": "(8)",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 827,
                    "end": 830,
                    "text": "(9)",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 831,
                    "end": 835,
                    "text": "(10)",
                    "ref_id": null
                },
                {
                    "start": 836,
                    "end": 840,
                    "text": "(11)",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1003,
                    "end": 1007,
                    "text": "(12)",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 1303,
                    "end": 1307,
                    "text": "(11,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1308,
                    "end": 1311,
                    "text": "13)",
                    "ref_id": "BIBREF17"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "A growing body of evidence suggests that the multiple amino acid substitutions in the Sprotein reduce the dependency of the virus on the serine protease TMPRSS2, compared to the Delta VoC (14) . The altered usage of TMPRSS2 by Omicron appears to make the virion more dependent on low-pH endosomes and the cathepsin entry pathway (14) (15) (16) .",
            "cite_spans": [
                {
                    "start": 188,
                    "end": 192,
                    "text": "(14)",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 329,
                    "end": 333,
                    "text": "(14)",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 334,
                    "end": 338,
                    "text": "(15)",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 339,
                    "end": 343,
                    "text": "(16)",
                    "ref_id": "BIBREF21"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "This highlights a considerable genetic flexibility of SARS-CoV-2 to adapt to different cell entry pathways, and may render the S-protein dependent entry a rather difficult target for powerful pan-interference strategies against SARS-CoV-2. 4 By engaging a multicycle drug repurposingscreen against coronaviruses we previously identified and validated several broadly acting compounds against SARS-CoV-2 infection of human nasal and bronchial airway epithelial explant cultures (HAEEC) grown at air liquid interface, namely, Methylene blue (MB), Mycophenolic acid (MPA), and Posaconazole (POS) (2) .These compounds have been used in the clinics for unrelated applications, and can be considered for repurposing against SARS-CoV-2. Here we report that these compounds strongly inhibit SARS-CoV-2 Omicron, along with the antihelminthic drug niclosamide (Niclo). Finally, we provide evidence for SARS-CoV-2 persistent infection of HAEEC.",
            "cite_spans": [
                {
                    "start": 240,
                    "end": 241,
                    "text": "4",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 593,
                    "end": 596,
                    "text": "(2)",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "The partial immunity against circulating Omicron subvariants BA.1 and BA. is not known, these compounds do not inhibit SARS-CoV-2 cell entry, and have little effects on viral genome replication, but strongly inhibit the release of infectious progeny to the apical medium, indicating that they affect one or several post replication steps, such as particle formation or egress (2). 5 Nasal HAEEC (Epithelix, MucilAir\u2122) grown at air-liquid interface (ALI) were apically inoculated with Omicron BA.1 (1,000 TCID 50 per tissue) and treated with compounds added to the basolateral medium one day post infection (pi). Following five consecutive days of daily treatment and apical sampling, infectious virus titer was determined with 50% tissue culture infectious dose (TCID 50 ) assays. Treatments with MB, MPA, and POS strongly inhibited the release of Omicron progeny (Fig. 1A) , similarly as previously observed withthe Alpha, Beta, Gamma, and Delta VoC (2). The basolateral medium had no detectable virus titer, akin to the earlier study (2) . The Omicron titers on the apical side, however, were in the range of 4.5 to 4.9-log 10 TCID 50 /ml as early as one day pi Fig. 1B and 1C ). Importantly, we could not detect evidence that MB and MPA induced phospholipidosis (Suppl. Fig. 2 ). Phospholipidosis manifests itself by a foamy appearance of internal cellular membranes likely owing to disregulated membrane signalling, sorting or transport (18) . It was reported that cationic amphiphilic drugsmay have unspecific antiviral activity correlated with phospholipidosis, for example compounds such as chloroquine, that had been discussed for repurposing in the early days of COVID-19 (19) .",
            "cite_spans": [
                {
                    "start": 381,
                    "end": 382,
                    "text": "5",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1036,
                    "end": 1039,
                    "text": "(2)",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 1441,
                    "end": 1445,
                    "text": "(18)",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 1681,
                    "end": 1685,
                    "text": "(19)",
                    "ref_id": "BIBREF25"
                }
            ],
            "ref_spans": [
                {
                    "start": 864,
                    "end": 873,
                    "text": "(Fig. 1A)",
                    "ref_id": "FIGREF7"
                },
                {
                    "start": 1164,
                    "end": 1178,
                    "text": "Fig. 1B and 1C",
                    "ref_id": "FIGREF7"
                },
                {
                    "start": 1273,
                    "end": 1279,
                    "text": "Fig. 2",
                    "ref_id": "FIGREF8"
                }
            ],
            "section": "MB, MPA and POS reduce extracellular SARS-CoV-2 Omicron progeny levels"
        },
        {
            "text": "We next compared the susceptibility of human primary epithelial explant cells of nasal and bronchial origin to Omicron BA.1 infection. Our results indicate that Omicron similarly infected both nasal and bronchial lung epithelial cells yielding apical titers in the range of 10 4 to 10 5 TCID 50 /ml (Fig.2) . These results suggest that bronchial cells can be used as a model for drug assessment against SARS-CoV-2 Omicron, and are in agreement with a 6 report using ex vivo cultures, where Omicron exhibited higher replication in bronchial cells than in lung parenchymal cells mimicking alveoli of the lower respiratory tract (16) .",
            "cite_spans": [
                {
                    "start": 626,
                    "end": 630,
                    "text": "(16)",
                    "ref_id": "BIBREF21"
                }
            ],
            "ref_spans": [
                {
                    "start": 299,
                    "end": 306,
                    "text": "(Fig.2)",
                    "ref_id": "FIGREF8"
                }
            ],
            "section": "Comparable growth of SARS-CoV-2 Omicron in nasal and bronchial HAEEC"
        },
        {
            "text": "To further address theneed of acute medical treatment options with broadly available, safe and effective antivirals, we tested if Niclo inhibited Omicron infection of bronchial HAEEC. Niclo is FDA-approved for the treatment of tapeworm infections. It acts as a protonophore and has broad anti-helminthic and antiviral activity owing to its ability to neutralize acidic cytoplasmic membrane compartments, as well as its effects on membrane trafficking and cell signaling processes (20) (21) (22) (23) . Recently, Niclo was shown to inhibit infection of primary human bronchial epithelial cells with SARS-CoV-2 Alpha, Beta, and Delta VoC (1).",
            "cite_spans": [
                {
                    "start": 480,
                    "end": 484,
                    "text": "(20)",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 485,
                    "end": 489,
                    "text": "(21)",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 490,
                    "end": 494,
                    "text": "(22)",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 495,
                    "end": 499,
                    "text": "(23)",
                    "ref_id": "BIBREF33"
                }
            ],
            "ref_spans": [],
            "section": "Niclosamide inhibits SARS-CoV-2 Omicron infection of bronchial HAEEC"
        },
        {
            "text": "To test if Niclo affected SARS-CoV-2 Omicron infection, we apically inoculated Omicron onto bronchial HAEEC, and treated the cells with different concentrations of Niclo (20, 10, 5, and 1\u00b5M) one day pi for up to day 8 in daily treatments and apical sampling, followed by TCID 50 titration of infectious progeny production. While 1\u00b5M of Niclo had no effect on Omicron, and 20\u00b5M was toxic for the cells, a daily treatment with intermediate concentrations of 5 or 10\u00b5M reduced the infectious titer of Omicron at days 3 to 8 up to 2 log 10 (Fig.3) . Similarly we could not detect evidence that Niclo induced phospholipidosis (Suppl. Fig. 2) . These results were similar to the ones with the Alpha, Beta, and Delta VoC reported earlier (1) . Notably, our effective concentrations of Niclo were slightly We took apical samples from the Omicron infected, DMSO control nasal HAEEC cells (presented in Fig. 1 ) for up to 15 days, and found a continuous titer between about 10 4 and 10 5 TCID50/ml in the apical milieu (Fig. 4A) . The RT-qPCR genome equivalents were between about 10 7 and 10 9 copies / ml, indicating continued production and release of viral components over several weeks. In accordance, infected nasal HAEEC cells fixed at 7d and 21d pi followed by RNA FISH staining demonstrated the presence of intracellular SARS-CoV-2 ORF1ab RNA(+) fluorescent puncta predominantly in the cell layer near the apical side of the pseudo-tissue (Fig. 4B) . Similarly, the 21d infected HAEEC cells also exhibited a clear staining of the SARS-CoV-2 ORF1ab RNA(+), albeit to a lesser extent.",
            "cite_spans": [
                {
                    "start": 731,
                    "end": 734,
                    "text": "(1)",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [
                {
                    "start": 536,
                    "end": 543,
                    "text": "(Fig.3)",
                    "ref_id": "FIGREF9"
                },
                {
                    "start": 629,
                    "end": 636,
                    "text": "Fig. 2)",
                    "ref_id": "FIGREF8"
                },
                {
                    "start": 893,
                    "end": 899,
                    "text": "Fig. 1",
                    "ref_id": "FIGREF7"
                },
                {
                    "start": 1009,
                    "end": 1018,
                    "text": "(Fig. 4A)",
                    "ref_id": "FIGREF10"
                },
                {
                    "start": 1438,
                    "end": 1447,
                    "text": "(Fig. 4B)",
                    "ref_id": "FIGREF10"
                }
            ],
            "section": "Niclosamide inhibits SARS-CoV-2 Omicron infection of bronchial HAEEC"
        },
        {
            "text": "Together, these results support the notion that HAEEC can be infected with SARS-CoV-2 for periods of at least several weeks. This gives rise to a situation that resembles a persistent infection, where virus is steadily released without overt tissue death.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Niclosamide inhibits SARS-CoV-2 Omicron infection of bronchial HAEEC"
        },
        {
            "text": "Persistence in vivo may enhance the chance for viral recombination, which requires that two or more different infectious agents are present in the same cell. A survey of SARS-CoV-2 genomes from UK firstly observed mosaic genomes structures of Alpha VoC with other co circulating variants, likely to be from recombinant origin (37) . Then, other potential SARS-CoV-2 recombinant lineage sequences were deposited on genomic databases and currently labelled XA to XL by the PANGO lineage nomenclature (38) . 9 Similarly, as both the Delta and the Omicron VoC have been massively co-circulating in many countries across the world, it can be expected that Delta and Omicron recombinants will appear. In fact, this has recently been suggested in several independent preprints (39) (40) (41) , acknowledged by the WHO with the BA.1 x AY.4 recombinant, nicknamed 'Deltacron', and labelled XD in the PANGO lineage nomenclature (38) . Although it is presently unknown, if these recombinants will outcompete the known SARS-CoV-2 variants, virus recombinants raise concerns about increased transmission and pathogenicity. This issue requires continued monitoring, drug and vaccine development and explorations of repurposable drugs against COVID-19. ",
            "cite_spans": [
                {
                    "start": 326,
                    "end": 330,
                    "text": "(37)",
                    "ref_id": null
                },
                {
                    "start": 498,
                    "end": 502,
                    "text": "(38)",
                    "ref_id": null
                },
                {
                    "start": 505,
                    "end": 506,
                    "text": "9",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 770,
                    "end": 774,
                    "text": "(39)",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 775,
                    "end": 779,
                    "text": "(40)",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 780,
                    "end": 784,
                    "text": "(41)",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 918,
                    "end": 922,
                    "text": "(38)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Niclosamide inhibits SARS-CoV-2 Omicron infection of bronchial HAEEC"
        },
        {
            "text": "Niclo was purchased to Sigma Aldrich (cat#N3510-50G; lot #BCBD3349V) and solubilized according to manufacturer's instructions. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Niclosamide"
        },
        {
            "text": "Phospolipidosis assay was performed as described by Tummino and colleagues (19) . NEAA, 10\u00b5g/mL Hoechst, and 2\u00b5M Ethidium homodimer-2 (EthD-2), and imaged with ImageXpress Micro confocal (Molecular Devices) microscope.",
            "cite_spans": [
                {
                    "start": 75,
                    "end": 79,
                    "text": "(19)",
                    "ref_id": "BIBREF25"
                }
            ],
            "ref_spans": [],
            "section": "Phospolipidosis assay"
        },
        {
            "text": "This was carried out as published in Murer et al (2) . ",
            "cite_spans": [
                {
                    "start": 49,
                    "end": 52,
                    "text": "(2)",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "SARS-CoV-2 infection of nasal and bronchial HAEEC tissue and drug treatment"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2). PloS one",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Weiss",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Touret",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Baronti",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gilles",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hoen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nougair\u00e8de",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "",
            "volume": "16",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0260958"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Murer",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Volle",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Andriasyan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Petkidis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gomez-Gonzalez",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.crviro.2022.10001913"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "World Health Organization, weekly epidemiological update on COVID-19 -22",
            "authors": [],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "European Centre for Disease Prevention and Control (ECDC) SARS-CoV-2 variants dashboard",
            "authors": [],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Genomic epidemiology of SARS-CoV-2 with global subsampling",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Nextstrain",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Evidence for a mouse origin of the SARS-CoV-2 Omicron variant",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "J"
                    ],
                    "last": "Shan",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Huan",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Qian",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Journal of genetics and genomics",
            "volume": "48",
            "issn": "12",
            "pages": "1111--1121",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jgg.2021.12.003"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Omicron (B.1.1.529) Variant. 2021, access 23",
            "authors": [],
            "year": 2022,
            "venue": "Centers for Disease Control And Prevention. Science Brief",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Antibody evasion properties of SARS-CoV-2 Omicron sublineages",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Iketani",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1038/s41586-022-04594-4"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Comparative transmission of SARS-CoV-2 Omicron",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Allen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Tessier",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Turner",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Anderson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Blomquist",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Simons",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "617.2) variants and the impact of vaccination: national cohort study",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2022.02.15.22271001"
                ]
            }
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Omicron Variant Neutralization in Serum from Vaccinated and Convalescent 14",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "The New England journal of medicine",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Persons",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "386",
            "issn": "",
            "pages": "698--700",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Lauring",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Tenforde",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Chappell",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gaglani",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Ginde",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Mcneal",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "BMJ",
            "volume": "376",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1136/bmj-2021-069761"
                ]
            }
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Analysis of SARS-CoV-2 Omicron Neutralization Data up to 2021-12-22",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Netzl",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tureli",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Legresley",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "M\u00fchlemann",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "H"
                    ],
                    "last": "Wilks",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Smith",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2021.12.31.474032"
                ]
            }
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nyberg",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "M"
                    ],
                    "last": "Ferguson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "G"
                    ],
                    "last": "Nash",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "H"
                    ],
                    "last": "Webster",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Flaxman",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Andrews",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "Lancet",
            "volume": "",
            "issn": "22",
            "pages": "462--469",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Advance online publication",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "462--469",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(22"
                ]
            }
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Meng",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abdullahi",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Ferreira",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Goonawardane",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Saito",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Kimura",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "Nature",
            "volume": "603",
            "issn": "7902",
            "pages": "706--714",
            "other_ids": {
                "DOI": [
                    "10.1038/s41586-022-04474-x"
                ]
            }
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerging microbes & infections",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "L"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Meng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "11",
            "issn": "",
            "pages": "277--283",
            "other_ids": {
                "DOI": [
                    "10.1080/22221751.2021.202332915"
                ]
            }
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ho",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Cheung",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "C"
                    ],
                    "last": "Ng",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ching",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Lai",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "Nature",
            "volume": "603",
            "issn": "7902",
            "pages": "715--720",
            "other_ids": {
                "DOI": [
                    "10.1038/s41586-022-04479-6"
                ]
            }
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Omicron (BA.1) and Sub-Variants (BA.1, BA.2 and BA.3) of SARS-CoV-2 Spike Infectivity and Pathogenicity: A Comparative Sequence and Structural-based Computational Assessment",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Karuppanan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Subramaniam",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2022.02.11.480029"
                ]
            }
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Drug induced phospholipidosis: an acquired lysosomal storage disorder",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Shayman",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abe",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Biochimica et biophysica acta",
            "volume": "1831",
            "issn": "3",
            "pages": "602--611",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Tummino",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "V"
                    ],
                    "last": "Rezelj",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Fischer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Fischer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "O&apos;meara",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Monel",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Science",
            "volume": "373",
            "issn": "6554",
            "pages": "541--547",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "The biology and toxicology of molluscicides",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Andrews",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Thyssen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lorke",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Bayluscide. Pharmacology& therapeutics",
            "volume": "19",
            "issn": "2",
            "pages": "245--295",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jurgeit",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mcdowell",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Moese",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Meldrum",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Schwendener",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [
                        "F"
                    ],
                    "last": "Greber",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "PLoS pathogens",
            "volume": "8",
            "issn": "10",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1371/journal.ppat.1002976"
                ]
            }
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "D"
                    ],
                    "last": "Fonseca",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "H"
                    ],
                    "last": "Diering",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Bidinosti",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dalal",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Alain",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "D"
                    ],
                    "last": "Balgi",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "Y"
                    ],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "ACS infectious diseases",
            "volume": "6",
            "issn": "5",
            "pages": "909--915",
            "other_ids": {
                "DOI": [
                    "10.1021/acsinfecdis.0c00052"
                ]
            }
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Host gene variability and SARS-CoV-2 infection: A review article",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Kaidashev",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Shlykova",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Izmailova",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Torubara",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yushchenko",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tyshkovska",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Heliyon",
            "volume": "7",
            "issn": "8",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.heliyon.2021.e07863"
                ]
            }
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Virus Infection Variability by Single-Cell Profiling",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Suomalainen",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [
                        "F"
                    ],
                    "last": "Greber",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Viruses",
            "volume": "13",
            "issn": "8",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.3390/v13081568"
                ]
            }
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "L"
                    ],
                    "last": "Pereira",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ahmad",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Byku",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "W"
                    ],
                    "last": "Cummins",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Morris",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Owens",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Mayo Clinic proceedings",
            "volume": "96",
            "issn": "2",
            "pages": "446--463",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Preparation and pharmacodynamics of niclosamide micelles",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Tian",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "Journal of Drug Delivery Science and Technology",
            "volume": "68",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jddst.2021.103088"
                ]
            }
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Cairns",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Dulko",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Griffiths",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Golan",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Trinquart",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "JAMA network open",
            "volume": "5",
            "issn": "2",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1001/jamanetworkopen.2021.44942"
                ]
            }
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19. The Lancet regional health",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Backer",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Sj\u00f6bring",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sonne",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Weiss",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hostrup",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "K"
                    ],
                    "last": "Johansen",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Europe",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.lanepe.2021.100084"
                ]
            }
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rambaut",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Loman",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "G"
                    ],
                    "last": "Pybus",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Barclay",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Barret",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Carabelli",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Establishment and maintenance of a persistent infection of L132 cells by human coronavirus strain 229E",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Chaloner Larsson",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Johnson-Lussenburg",
                    "suffix": ""
                }
            ],
            "year": 1981,
            "venue": "Archives of virology",
            "volume": "69",
            "issn": "2",
            "pages": "117--129",
            "other_ids": {
                "DOI": [
                    "10.1007/BF01315155"
                ]
            }
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Acute and persistent infection of human neural cell lines by human coronavirus OC43",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Arbour",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "C\u00f4t\u00e9",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Lachance",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tardieu",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "R"
                    ],
                    "last": "Cashman",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Talbot",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Journal of virology",
            "volume": "73",
            "issn": "4",
            "pages": "3338--3350",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "G"
                    ],
                    "last": "Maponga",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Jeffries",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Tegally",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "D"
                    ],
                    "last": "Sutherland",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Wilkinson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lessels",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.2139/ssrn.4014499"
                ]
            }
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Choi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Choudhary",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Regan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Sparks",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "F"
                    ],
                    "last": "Padera",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Qiu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "The New England journal of medicine",
            "volume": "383",
            "issn": "23",
            "pages": "2291--2293",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Persistent SARS-CoV-2 Infection in a Patient With Non-hodgkin Lymphoma: Intra-Host Genomic Diversity Analysis",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bianco",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Capozzi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Del Sambro",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Simone",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Pace",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Rondinone",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "Frontiers in Virology",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.3389/fviro.2022.758191"
                ]
            }
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "SARS-CoV-2 persistence is associated with antigen-specific CD8 Tcell responses",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "K"
                    ],
                    "last": "Vibholm",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nielsen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Pahus",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "S"
                    ],
                    "last": "Frattari",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Olesen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Andersen",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "EBioMedicine",
            "volume": "64",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ebiom.2021.103230"
                ]
            }
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Recombinant SARS-CoV-2 genomes involving lineage B.1.1.7 in the UK",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Identification of a Novel SARS-CoV-2 Delta-Omicron Recombinant Virus in the United States",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Lacek",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Rambo-Martin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Batra",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sakaguchi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Peacock",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2022.03.19.484981"
                ]
            }
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bolze",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Basler",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Dei Rossi",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Roychoudhury",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Alexander",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2022.03.09.22272113"
                ]
            }
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Culture and identification of a \"Deltamicron\" SARS-CoV-2 in a three cases cluster insouthern France",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Colson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Fournier",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Delerce",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Million",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bedotto",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Houhamdi",
                    "suffix": ""
                }
            ],
            "year": 2022,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2022.03.03.22271812"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "of SARS-CoV-2 necessitate the development of an arsenal of broad acting antiviral compounds. To address this need we tested the repurposing potential of several previously identified anti-SARS-CoV-2 compounds against the Omicron variant BA.1 (B.1.1.529.1), a close relative to the currently circulating BA.2VoC. The S-protein of BA.1 differs from the BA.2 S-protein by 12 amino acids, one nucleotide insertion and 5 nucleotide deletions (17). We first focused on three compounds previously identified for their broad anti-coronavirus activity in cell culture, MB, MPA and POS (2). MB, MPA, and POS inhibit infection of primary human airway epithelial explant cultures (HAEEC) of nasal origin by the Wuhan strain, as well as Alpha, Beta, Gamma, and Delta VoC. Although their mode-of-inhibition",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Suppl Fig. 1). MB, MPA, and POS reduced the average SARS-CoV-2 Omicron titers, albeit with different kinetics and efficiencies. Compared to the DMSO control-treated cells, MP, MPA or POS reduced the infection to 10 (\u00b12.9), 36 (\u00b118), and 58 (\u00b131)%, respectively, at day one post treatment, and to 6.4 (\u00b12.3), 18 (\u00b14.3) 1.8 (\u00b10.4)% at day five post treatment, notably without apparent tissue lesion, basolateral medium leakage or cell toxicity (",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "higher than those used by Weiss et al., namely 5-10\u00b5M versus 1.25-5\u00b5M. This difference possibly reflects the post-exposure treatment in our case, versus the preexposure treatment by Weiss and colleagues, or alternatively, donor-to-donor variability of the HAEEC. Cell-to-cell and donor-to-donor variability can have a significant influence on the infection outcome both in vivo and in vitro(24)(25)(26). Taken together, Niclo may be considered as a potential inhibitor of SARS-CoV-2 with broad effects on VoC. of 34 patients(28). However, aerosolized formulations of Niclo may be worth testing against COVID-19, as they can be safely applied to human airways(28,29).Persistent infection of nasal HAEEC by SARS-CoV-2Although the origin of Omicron variant is still debated, a chronic infection has been a distinct possibility. An early report of the COVID-19 Genomics Consortium UK(30) hypothesized that chronic infections may have played a role in the origin of the Alpha variant (B.1.1.7). This may not be far-fetched because human coronaviruses have been long known to establish and maintain persistent infections in vitro. For example, the alpha coronavirus CoV-229E maintains a persistent infection of human fetal lung cells (L132)for up to 300 passages over a period of two years and produces infectious progeny(31).The beta CoV-OC43 persists in infected neurons, astrocytes, microglial, and oligodendrocytes cell lines andwas shown to release infectious particles for up to 25 passages andmore than one hundred days(32).The question if SARS-CoV-2 persists in vivo has been debated, partly, because it is difficult to discriminate between a persistent infection and a second infection. A case report from South Africa, however, provided evidence that a 22 years old, HIV-positive woman under anti-retroviral therapy was persistently infected with SARS-CoV-2(33).Over the course of 9 months, the virus acquired 21 nucleotide mutations, including 10 in the spike coding sequence leading to the substitution of six amino acids in the receptor binding domain (RBD), the deletion of three amino acids in the N-terminal domain, and the substitution of two amino acids in the S2 subunit. In addition, a 45 years old immunocompromised man produced infectious SARS-CoV-2 for up to 150 days, and was for SARS-CoV-2 persistence, as indicated by RT-qPCR in pharyngeal samples from 26 individuals at 15-44 days and from 5-individuals at 85-105 days post recovery(36).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "grown in DMEM (Sigma Aldrich, Cat #D6429) supplemented with 4% of FCS (Gibco, Cat #10270-106), and 1X of NEAA (Sigma Aldrich, Cat #M7145). Virus titers were determined by TCID 50 titration on VeroE6 cells according to the Spearman-K\u00e4rber method.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "nasal HAEEC (MucilAir\u2122, Epithelix SA,Geneva, Switzerland) cultured on transwell inserts (24-well plate) were maintained at air-liquid interface according to the supplier's instructionsand cell culture medium (Epithelix SA,Geneva, Switzerland, cat#EP05MM,). Nasal HAEEC from a pool of fourteen healthy donors (Batch nr: MP010). Human bronchial were obtained from an individual donor (Donor 793, Epithelix SA, Geneva, Switzerland). Cells have been then seeded on Type IV collagen (Sigma Aldrich,cat#C5533) coated inserts (24-well plate) and amplified with PneumaCult\u2122-Ex Basal Medium (Stemcell cat#05009) supplemented 1X with PneumaCult\u2122-Ex 50X-Supplement (Stemcell, cat#05019) and hydrocortisone (Stemcell, cat#07925). Then cell have been differentiated with PneumaCult\u2122-ALI Base Medium (Stemcell, cat#05002) supplemented with 1X of PneumaCult\u2122-ALI 10X supplement (Stemcell, cat#05003), hydrocortisone (Stemcell, cat#07925), heparin (Stemcell, cat#07980), and 150 ng/mL of retinoic acid (Sigma Aldrich, cat#R2625). permeabilized with absolute methanol overnight at -20\u00b0C. Samples were rehydrated by incubation with 75%, 50%, 25%, 0% of ice-cold methanol and PBST (Tween-20, 0.1%) for 5 min each. Rehydrated samples were washed on ice with a vol/vol solution of 5XSSCT /PBST for 5min, afterwards 5XSSCT alone for 5min. Samples were then FISH-stained against SARS-CoV-2 ORF1a mRNA using ViewRNA mRNA FISH assay according to the manufacturer's instructions (ThermoFisher) with some modifications. Samples were hybridized with the SARS-CoV-2 targeting probes overnight at 40\u00b0C, then the subsequent pre-amplifier, amplifier, and Alexa Fluor 546 labeled probes hybridizations steps were done for 2h each at 40\u00b0C. SARS-CoV-2 targeting probes were custom-made #6007037-01 directed against the ORF1a sequences between positions 401-1327 (ThermoFisher). Subsequently, cells were incubated in PBS containing DAPI for 10 min at RT. Finally, the stained inserts have been detached from their plastic support, then slide/coverslip mounted, and then imaged using a SP8 confocal microscope (Leica).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Briefly, VeroE6 cells were seeded on a 96-well black imaging plate at a density of 15,000 cells per well and grown overnight in DMEM supplemented with 10%FCS and 1X NEAA.Then the medium was replaced with DMEM supplemented with 10%FCS, 1X NEAA, 7.5\u00b5M NBD-PE (ThermoFisher, cat#N360), and three concentrations of MB, MPA, Niclo, NH4Cl, and Amiodarone and incubated for 24hours at 37\u00b0C. Water and DMSO were used as solvent controls. Finally, cells were stained for 20 min at 37\u00b0C with a solution of DMEM supplemented with 100mM sodium pyruvate, 200mM L-Glutamine, 10% FCS, 1X",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "This was carried out as published in Murer et al(2).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "MPA, MB, and POS inhibit SARS-CoV-2 Omicron variant infection of nasal HAEEC. Antiviral effects of drug treatment represented as means \u00b1 SEM of three independent replicates. Nasal HAEEC grown at ALI were inoculated apically with 1,000 TCID 50 units of SARS-CoV2 Omicron variant (day 0) and subjected to drug treatments in the basolateral medium, in a post-infection regimen starting at 1d pi. MB (10 \u03bcM), MPA (10 \u03bcM), and POS (20 \u03bcM) were administered daily until day 6. Remdesivir (10\u03bcM) and DMSO served as drug treatment controls. SARS-CoV-2 released at the apical side was collected daily by apical washing and quantified by TCID 50 titration. A) Global fold change in virus titer. The baseline levels represent the apical means \u00b1 SEM of virus titer from the DMSO control sample at 1d pi (prior treatment). B) Relative change in virus titers of the treated inserts compared to the DMSO control C) Microscopic images of infected / treated nasal HAEEC at 6d pi. Pictures were taken through an inverted light microscope (Axiovert 135) at 100X magnification using CellF software (Olympus Soft Imaging Solutions GmbH, version 3.0).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "SARS-CoV-2 Omicron infection of nasal and bronchial HAEEC. Nasal and bronchial HAEEC grown at ALI were inoculated apically in duplicate with 1,000 TCID50 units of SARS-CoV2 Omicron. Virus released at the apical side was collected daily by apical washing and quantified by TCID 50 titration. Data are represented as means \u00b1 SD of virus titers.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "Niclosamide inhibits SARS-CoV-2 Omicron infection of bronchial HAEEC. Bronchial HAEEC grown at ALI were inoculated apically with 1,000 TCID 50 units of SARS-CoV2 Omicron (day 0), and treated daily with Niclo in the basolateral medium titers of two independent replicates. Baseline levels represent the apical means \u00b1 SEM of virus titer inthe DMSO control sample at 1dpi. B) Microscopic images of infected / treated nasal HAEEC at 6d pi. Pictures were taken through an inverted light microscope (Axiovert 135) at 100X magnification using CellF software (Olympus Soft Imaging Solutions GmbH, version 3.0).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "Persistent infection of nasal HAEEC by SARS-CoV-2. A) SARS-CoV-2 Omicron collected at the apical side of a duplicate (TCID 50 means\u00b1SD). Virus titers (TCID 50 ) are shown by bars (left y-axis) and virus genome copy numbers from RT-qPCR measurements are represented by blue dots (right y-axis). The virus genome copy numbers at days 12 and 15pi were not tested (nr). B) Intracellular presence of SARS-CoV-2 RNA (+) genome in HAEEC fixed at 7d and 21dpi, respectively. SARS-CoV-2 genomes (+) were stained by RNA fluorescence in situ hybridization (FISH) using oligonucleotide probes targeting the viral ORF1ab. The scale bar represents 30\u00b5m. A 3D",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": [
        {
            "text": "We acknowledge financial support from the Swiss National Science foundation (SNSF) to UFG (31CA30_196177/1) and a special Coronavirus Research grant from the University of Zurich to UFG. We are grateful to Dr. Adriano Aguzzi and Dr. Simone Hornemann for granting generous access to their BSL3 laboratory, and Dr. Maarit Suomalainen for discussions.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Acknowledgements"
        }
    ]
}